Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis | Canada Hyperbarics Skip to main content
Case Report Pediatr Crit Care Med 2006

Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis

De Decker K, Van Poucke S, Wojciechowski M, Ieven M, Colpaert C, Vogelaers D, et al. — Pediatr Crit Care Med, 2006

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on a 12-year-old girl with severe injuries who developed a fungal infection and was successfully treated with surgery, hyperbaric oxygen therapy, and antifungal medications.

What They Found

A 12-year-old female patient with extensive injuries developed necrotizing fasciitis caused by two fungi, Mucor and Trichosporon species. She made an excellent recovery after receiving aggressive surgery, hyperbaric oxygen therapy, and a combination of amphotericin B and posaconazole.

What This Means for Canadian Patients

This case suggests that hyperbaric oxygen therapy, when combined with surgery and antifungal drugs, may be a beneficial treatment option for severe fungal necrotizing fasciitis. While not a standard treatment for this specific condition, it highlights a potential role for HBOT in complex infections, which Canadian patients might discuss with their healthcare providers.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a single case report, these findings cannot be generalized to a larger patient population and require further investigation.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 16878050
Year Published 2006
Journal Pediatr Crit Care Med
MeSH Terms Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Fasciitis, Necrotizing; Female; Humans; Mucormycosis; Mycoses; Triazoles; Trichosporon

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.